Article Figures & Data
Figures
- Figure 1.
Pre–post comparison of willingness, comfort, and confidence with medication-assisted treatment (MAT).
- Figure 2.
Pre–post comparison of importance and confidence items, care process and patient interactions.
- Appendix Figure 1.
Scree plots from exploratory factor analyses of pre-test medication-assisted treatment (MAT) importance and confidence measures.
Tables
- Table 1.
Exploratory Factor Analysis Loadings for Medication-Assisted Treatment (MAT) Importance and Confidence Items
Importance items Confidence items Care process Patient interaction Care process Patient interaction Implementing Buprenorphine opioid treatment, managing its long-term maintenance on medications 0.87 0.91 Matching patients to appropriate MAT medications (methadone, buprenorphine, naltrexone) 0.86 0.89 Defining goals of MAT with patients 0.83 0.88 Implementing Naltrexone opioid treatment, managing its long-term maintenance on medications 0.80 0.88 Discussing MAT medication effects and side effects with patients 0.78 0.84 Detailing MAT approaches (methadone, buprenorphine, naltrexone) and medication protocols for opioid use disorders with patients 0.78 0.84 Treating specialized populations with MAT 0.73 0.84 Discussing the effectiveness of MAT for opioid use disorders with patients 0.72 0.79 Familiarizing patients with laws, regulations and oversights involved with agonist-based and partial agonist treatments 0.69 0.78 Using reflective listening 0.99 0.99 Using open body language 0.86 0.89 Demonstrating assertive compassion 0.77 0.78 Notes: Extraction method was maximum likelihood; rotation method was Promax with Kaiser normalization. Loadings <0.20 are not shown. All loadings are from the pattern matrix.
- Table 2.
Reliability Analysis for Pre- and Post- MAT Training Evaluation Items (Cronbach's α)
Items Pre Post Confidence Care process (n = 9) 0.96 0.93 Patient interaction (n = 3) 0.92 0.94 Importance Care process (n = 9) 0.94 0.95 Patient interaction (n = 3) 0.92 0.96
